Wim E. Terpstra
Wim E. Terpstra publishes mostly in Hematology, Oncology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #1,853,758 of 7,710,434 ranked researchers
- Rank in Netherlands
- #40,741 of 107,149
- Works
- 60
- Citations
- 1.6k
- Citations per work
- 26.5
What does Wim E. Terpstra research?
Wim E. Terpstra's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3557.8%
- Medicine3557.8%
- Everything else2135.3%
- Life Sciences46.9%
- 1Hematology21% of their works
- 2Oncology16% of their works
- 3Genetics8% of their works
- 4Molecular Biology7% of their works
- 5Surgery7% of their works
- 6Pathology and Forensic Medicine6% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Venous Thromboembolism Diagnosis and Management
- Chronic Lymphocytic Leukemia Research
Which keywords describe Wim E. Terpstra's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Rituximab, Diagnosis Criteria, International Myeloma Working Group, Acute Myeloid Leukemia, AML and Classification.
- Chronic Lymphocytic Leukemia
- Thrombosis
- Myelofibrosis
- Graft-versus-Host Disease
- Antithrombotic Therapy
- Classification
- AML
- Diagnosis Criteria
- Prognostic Factors
- Hematopoietic Stem Cells
- Rituximab
- International Myeloma Working Group
- Acute Myeloid Leukemia
- Lymphoma
- Bone Marrow Niche
- JAK2 Mutation
- Platelets
- Venous Thromboembolism
- Genomic Aberrations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Hematopoietic Stem Cells152 topics
- Prognostic Factors142 topics
- Rituximab132 topics
- Diagnosis Criteria101 topic
- International Myeloma Working Group101 topic
- AML91 topic
- Acute Myeloid Leukemia91 topic
- Classification81 topic
- Lymphoma81 topic
- Antithrombotic Therapy61 topic
- Bone Marrow Niche61 topic
- Graft-versus-Host Disease61 topic
- JAK2 Mutation61 topic
- Myelofibrosis61 topic
- Platelets61 topic
- Thrombosis61 topic
- Venous Thromboembolism61 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
Where does Wim E. Terpstra work?
Wim E. Terpstra's main affiliation in the publication record is OLVG, Netherlands.
How many publications and citations does Wim E. Terpstra have?
OpenAlex counts 60 works and 1,592 citations for Wim E. Terpstra, an h-index of 23, ranking #1,853,758 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Wim E. Terpstra. Posts are plain text and can be reported.